Migraine is a severe neurological disorder that affects a significant proportion of the population. Prevalence estimates vary between 12 and 25% depending on the population studied. The disorder has a significant genetic component.
In this interview, Andrew talks to Professor Lyn Griffiths on her very promising research which looks at genetic profiling in conjunction with nutraceutical therapies. These clinical trials highlight the potential importance of nutritional interventions in this disorder.
Professor Lyn Griffiths is the Executive Director of the Institute of Health and Biomedical Innovation (IHBI), the largest inter-disciplinary research institute at the Queensland University of Technology (QUT). She is a molecular geneticist with over 21 years experience studying human complex gene disorders with specific expertise in human gene mapping and gene expression analyses, including migraine, cardiovascular disease and several types of cancer.